Logo image of PVL.PA

PLASTIVALOIRE (PVL.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:PVL - FR0013252186 - Common Stock

1.73 EUR
0 (0%)
Last: 12/10/2025, 2:07:57 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to PVL. PVL was compared to 72 industry peers in the Chemicals industry. PVL has a bad profitability rating. Also its financial health evaluation is rather negative. PVL is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year PVL has reported negative net income.
In the past year PVL had a positive cash flow from operations.
In the past 5 years PVL reported 4 times negative net income.
In the past 5 years PVL always reported a positive cash flow from operatings.
PVL.PA Yearly Net Income VS EBIT VS OCF VS FCFPVL.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M 80M

1.2 Ratios

PVL has a Return On Assets of -6.04%. This is amonst the worse of the industry: PVL underperforms 80.56% of its industry peers.
Looking at the Return On Equity, with a value of -23.13%, PVL is doing worse than 83.33% of the companies in the same industry.
PVL's Return On Invested Capital of 1.38% is on the low side compared to the rest of the industry. PVL is outperformed by 65.28% of its industry peers.
PVL had an Average Return On Invested Capital over the past 3 years of 2.18%. This is below the industry average of 7.08%.
Industry RankSector Rank
ROA -6.04%
ROE -23.13%
ROIC 1.38%
ROA(3y)-3.76%
ROA(5y)-2.43%
ROE(3y)-13.19%
ROE(5y)-8.49%
ROIC(3y)2.18%
ROIC(5y)N/A
PVL.PA Yearly ROA, ROE, ROICPVL.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

With a Operating Margin value of 1.26%, PVL is not doing good in the industry: 70.83% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of PVL has declined.
The Gross Margin of PVL (48.03%) is better than 69.44% of its industry peers.
In the last couple of years the Gross Margin of PVL has grown nicely.
Industry RankSector Rank
OM 1.26%
PM (TTM) N/A
GM 48.03%
OM growth 3Y-24.59%
OM growth 5Y-25.32%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.37%
GM growth 5Y2.85%
PVL.PA Yearly Profit, Operating, Gross MarginsPVL.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PVL is destroying value.
PVL has about the same amout of shares outstanding than it did 1 year ago.
PVL has about the same amout of shares outstanding than it did 5 years ago.
PVL has a worse debt/assets ratio than last year.
PVL.PA Yearly Shares OutstandingPVL.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
PVL.PA Yearly Total Debt VS Total AssetsPVL.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

PVL has an Altman-Z score of 1.52. This is a bad value and indicates that PVL is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.52, PVL is doing worse than 79.17% of the companies in the same industry.
PVL has a Debt/Equity ratio of 1.24. This is a high value indicating a heavy dependency on external financing.
PVL has a Debt to Equity ratio of 1.24. This is amonst the worse of the industry: PVL underperforms 86.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.24
Debt/FCF N/A
Altman-Z 1.52
ROIC/WACC0.33
WACC4.14%
PVL.PA Yearly LT Debt VS Equity VS FCFPVL.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

PVL has a Current Ratio of 1.33. This is a normal value and indicates that PVL is financially healthy and should not expect problems in meeting its short term obligations.
PVL has a worse Current ratio (1.33) than 76.39% of its industry peers.
A Quick Ratio of 1.16 indicates that PVL should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.16, PVL perfoms like the industry average, outperforming 45.83% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 1.16
PVL.PA Yearly Current Assets VS Current LiabilitesPVL.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1

3. Growth

3.1 Past

The earnings per share for PVL have decreased strongly by -175.68% in the last year.
Looking at the last year, PVL shows a decrease in Revenue. The Revenue has decreased by -7.04% in the last year.
Measured over the past years, PVL shows a decrease in Revenue. The Revenue has been decreasing by -0.69% on average per year.
EPS 1Y (TTM)-175.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-80.95%
Revenue 1Y (TTM)-7.04%
Revenue growth 3Y1.28%
Revenue growth 5Y-0.69%
Sales Q2Q%-14.65%

3.2 Future

Based on estimates for the next years, PVL will show a very strong growth in Earnings Per Share. The EPS will grow by 62.61% on average per year.
The Revenue is expected to decrease by -1.09% on average over the next years.
EPS Next Y-1290%
EPS Next 2Y92.35%
EPS Next 3Y62.61%
EPS Next 5YN/A
Revenue Next Year-8.64%
Revenue Next 2Y-4.11%
Revenue Next 3Y-1.09%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PVL.PA Yearly Revenue VS EstimatesPVL.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
PVL.PA Yearly EPS VS EstimatesPVL.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2

4

4. Valuation

4.1 Price/Earnings Ratio

PVL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 10.08, which indicates a very decent valuation of PVL.
Based on the Price/Forward Earnings ratio, PVL is valued cheaper than 87.50% of the companies in the same industry.
PVL's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.51.
Industry RankSector Rank
PE N/A
Fwd PE 10.08
PVL.PA Price Earnings VS Forward Price EarningsPVL.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PVL is valued cheaply inside the industry as 98.61% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.43
PVL.PA Per share dataPVL.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

A more expensive valuation may be justified as PVL's earnings are expected to grow with 62.61% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y92.35%
EPS Next 3Y62.61%

0

5. Dividend

5.1 Amount

No dividends for PVL!.
Industry RankSector Rank
Dividend Yield N/A

PLASTIVALOIRE

EPA:PVL (12/10/2025, 2:07:57 PM)

1.73

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-28 2025-08-28
Earnings (Next)12-16 2025-12-16/amc
Inst Owners1.03%
Inst Owner ChangeN/A
Ins Owners54.69%
Ins Owner ChangeN/A
Market Cap38.28M
Revenue(TTM)703.54M
Net Income(TTM)-45.09M
Analysts45.71
Price Target1.43 (-17.34%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-9.68%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)3.47%
EPS NY rev (3m)13.66%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.82%
Revenue NY rev (3m)5.51%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.08
P/S 0.05
P/FCF N/A
P/OCF 2.01
P/B 0.2
P/tB 0.3
EV/EBITDA 3.43
EPS(TTM)-2.04
EYN/A
EPS(NY)0.17
Fwd EY9.92%
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)0.86
OCFY49.86%
SpS31.79
BVpS8.81
TBVpS5.7
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.04%
ROE -23.13%
ROCE 2.13%
ROIC 1.38%
ROICexc 1.74%
ROICexgc 2.14%
OM 1.26%
PM (TTM) N/A
GM 48.03%
FCFM N/A
ROA(3y)-3.76%
ROA(5y)-2.43%
ROE(3y)-13.19%
ROE(5y)-8.49%
ROIC(3y)2.18%
ROIC(5y)N/A
ROICexc(3y)2.53%
ROICexc(5y)N/A
ROICexgc(3y)3.11%
ROICexgc(5y)N/A
ROCE(3y)3.17%
ROCE(5y)N/A
ROICexgc growth 3Y-20.84%
ROICexgc growth 5Y-21.45%
ROICexc growth 3Y-19.92%
ROICexc growth 5Y-21.2%
OM growth 3Y-24.59%
OM growth 5Y-25.32%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.37%
GM growth 5Y2.85%
F-Score6
Asset Turnover0.94
Health
Industry RankSector Rank
Debt/Equity 1.24
Debt/FCF N/A
Debt/EBITDA 4.82
Cap/Depr 50.56%
Cap/Sales 2.96%
Interest Coverage 0.97
Cash Conversion 38.12%
Profit Quality N/A
Current Ratio 1.33
Quick Ratio 1.16
Altman-Z 1.52
F-Score6
WACC4.14%
ROIC/WACC0.33
Cap/Depr(3y)60.25%
Cap/Depr(5y)56.65%
Cap/Sales(3y)3.98%
Cap/Sales(5y)3.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-175.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-80.95%
EPS Next Y-1290%
EPS Next 2Y92.35%
EPS Next 3Y62.61%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.04%
Revenue growth 3Y1.28%
Revenue growth 5Y-0.69%
Sales Q2Q%-14.65%
Revenue Next Year-8.64%
Revenue Next 2Y-4.11%
Revenue Next 3Y-1.09%
Revenue Next 5YN/A
EBIT growth 1Y-70.23%
EBIT growth 3Y-23.63%
EBIT growth 5Y-25.84%
EBIT Next Year700%
EBIT Next 3Y105.04%
EBIT Next 5YN/A
FCF growth 1Y53.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-28.16%
OCF growth 3Y-26.28%
OCF growth 5Y-7.25%

PLASTIVALOIRE / PVL.PA FAQ

What is the ChartMill fundamental rating of PLASTIVALOIRE (PVL.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to PVL.PA.


Can you provide the valuation status for PLASTIVALOIRE?

ChartMill assigns a valuation rating of 4 / 10 to PLASTIVALOIRE (PVL.PA). This can be considered as Fairly Valued.


How profitable is PLASTIVALOIRE (PVL.PA) stock?

PLASTIVALOIRE (PVL.PA) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for PVL stock?

The Earnings per Share (EPS) of PLASTIVALOIRE (PVL.PA) is expected to decline by -1290% in the next year.